Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Intermolecular Inc    IMI

INTERMOLECULAR INC

(IMI)
  Report  
Real-time Quote. Real-time BATS EXCHANGE - 05/23 03:46:58 pm
1.1750 USD   0.00%
05/15WEISSLAW LLP : Investigates Intermolecular, Inc. Acquisition
PR
05/15NEWS ALERT : Monteverde & Associates PC is Investigating the Announced Buyout
PR
05/14INTERMOLECULAR : 1Q Earnings Snapshot
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

WeissLaw LLP : Investigates Intermolecular, Inc. Acquisition

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/15/2019 | 09:02pm EDT

NEW YORK, May 15, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Intermolecular, Inc. ("Intermolecular" or the "Company") (NASDAQ: IMI) in connection with the proposed acquisition of the Company by a wholly owned subsidiary of Merck KGaA.  Under the terms of the acquisition agreement valued at $62 million, shareholders will receive $1.20 per share in cash. 

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own IMI shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Visit our website
http://www.weisslawllp.com/

Or follow us on Twitter @MarketsAlert

WeissLaw is investigating whether Intermolecular's Board acted to maximize shareholder value prior to entering into the agreement. 

WeissLaw is concentrating its investigation on whether Intermolecular's Board conducted a fair process in agreeing to the proposed acquisition, and whether the proposed acquisition undervalues the Company. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com.

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-investigates-intermolecular-inc-acquisition-300851308.html

SOURCE WeissLaw LLP


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTERMOLECULAR INC
05/15WEISSLAW LLP : Investigates Intermolecular, Inc. Acquisition
PR
05/15NEWS ALERT : Monteverde & Associates PC is Investigating the Announced Buyout
PR
05/14INTERMOLECULAR : 1Q Earnings Snapshot
AQ
05/14INTERMOLECULAR : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/14INTERMOLECULAR INC : Results of Operations and Financial Condition, Financial St..
AQ
05/14INTERMOLECULAR : Reports First Quarter 2019 Financial Results
PR
05/07INTERMOLECULAR : Merck signs definitive agreement to acquire Intermolecular for ..
AQ
05/06Germany's Merck to Buy Intermolecular for $62 Million in All-Cash Deal
DJ
05/06INTERMOLECULAR INC : Entry into a Material Definitive Agreement, Other Events, F..
AQ
05/06INTERMOLECULAR : to be acquired by Merck KGaA, Darmstadt, Germany for $1.20 per ..
PR
More news